001130.KS
Daehan Flour Mills Co.,Ltd
KSEKRWEQUITY
Consumer Defensive
DELAYED
Last price
11,660.00
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
11,670.00
Prev close
11,660.00
Day high
11,710.00
Day low
11,470.00
Volume
3.07K
Market cap
$192.37B
P/E (TTM)
—
52W range
10,500.00 – 16,400.00
Day trading desk
Gap from prior close
+0.09%
Prior close 11,660.00
VWAP
11,537.29
+1.06% from price
Relative volume
0.14×
Quiet session
Session range
2.09%
11,470.00 – 11,710.00
Position in range
79%
Near session high
ATR (14D)
315.00
2.70% of price
Prior day high
11,690.00
PDH
Prior day low
11,350.00
PDL
Bid / ask spread
—
Quote not published
Session volume
3.47K
Avg 24.87K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.60%
+1.8%
1M
+4.20%
+0.9%
3M
-8.76%
-11.2%
6M
-24.63%
-36.5%
YTD
-20.19%
-32.2%
1Y
-21.27%
-41.4%
3Y
-10.31%
-85.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 001130.KS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
7.16M
Total on file
Fundamentals
Market cap$192.37B
Enterprise value$112.11B
Revenue (TTM)$1.38T
Gross profit$265.44B
EBITDA$84.67B
Net income$-40.48B
EPS (TTM)—
Free cash flow$170.39B
Total cash$364.68B
Total debt$281.61B
Book value / share—
Shares outstanding16.50M
Float9.22M
Short % of float—
Dividend yield3.43%
Beta (5Y)0.39
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue0.08
EV / EBITDA1.32
Gross margin19.18%
Operating margin2.00%
Profit margin-2.93%
Return on equity-3.86%
Return on assets1.82%
Debt / equity27.56
Current ratio1.50
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.38T | $1.37T | $1.44T | $1.37T | +0.0% |
| Operating revenue | $1.38T | $1.37T | $1.44T | $1.37T | +0.0% |
| Cost of revenue | $1.10T | $1.10T | $1.18T | $1.14T | +0.6% |
| Gross profit | $272.99B | $278.76B | $258.11B | $228.15B | -2.1% |
| Research & development | $611.96M | $776.12M | $445.19M | $298.86M | -21.2% |
| Selling, general & admin | $105.65B | $97.66B | $99.39B | $87.97B | +8.2% |
| Total operating expense | $305.18B | $206.46B | $203.30B | $184.88B | +47.8% |
| Operating income | -$32.19B | $72.31B | $54.81B | $43.27B | -144.5% |
| Net interest income | $9.28B | $12.50B | $5.06B | $13.48B | -25.8% |
| Pre-tax income | -$4.73B | $70.03B | $101.52B | $55.13B | -106.8% |
| Tax provision | $20.41B | $21.20B | $20.28B | $13.79B | -3.7% |
| Net income | -$25.26B | $48.74B | $81.20B | $41.16B | -151.8% |
| Net income to common | -$25.26B | $48.74B | $81.20B | $41.16B | -151.8% |
| Basic EPS | -1,518.80 | 2,925.70 | 4,871.80 | 2,469.70 | -151.9% |
| Diluted EPS | -1,518.80 | 2,925.70 | 4,871.80 | 2,469.70 | -151.9% |
| EBIT | $9.12B | $82.65B | $114.37B | $62.03B | -89.0% |
| EBITDA | $48.09B | $124.86B | $156.27B | $103.59B | -61.5% |
| Basic shares | 16.63M | 16.66M | 16.67M | 16.67M | -0.2% |
| Diluted shares | 16.63M | 16.66M | 16.67M | 16.67M | -0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $84.67B | $100.58B | $185.38B | $86.79B | -15.8% |
| Cash & short-term investments | $377.31B | $409.03B | $325.00B | $181.01B | -7.8% |
| Accounts receivable | $154.31B | $174.99B | $177.66B | $164.41B | -11.8% |
| Inventory | $181.45B | $198.09B | $185.28B | $249.35B | -8.4% |
| Total current assets | $727.29B | $798.43B | $714.23B | $615.43B | -8.9% |
| Property, plant & equipment | $349.33B | $325.69B | $335.82B | $334.17B | +7.3% |
| Goodwill & intangibles | $50.06B | $52.46B | $54.48B | $62.88B | -4.6% |
| Total assets | $1.53T | $1.56T | $1.40T | $1.32T | -1.6% |
| Total current liabilities | $474.81B | $476.95B | $360.10B | $344.70B | -0.4% |
| Current debt | $238.92B | $322.46B | $187.79B | $184.62B | -25.9% |
| Long-term debt | $12.70B | $7.90B | $13.30B | $19.68B | +60.8% |
| Total debt | $292.00B | $373.90B | $244.26B | $246.15B | -21.9% |
| Total liabilities | $525.62B | $523.13B | $407.39B | $399.08B | +0.5% |
| Retained earnings | $959.50B | $991.00B | $949.07B | $875.22B | -3.2% |
| Shareholder equity | $1.01T | $1.04T | $992.91B | $918.34B | -2.7% |
| Working capital | $252.48B | $321.49B | $354.14B | $270.73B | -21.5% |
| Net tangible assets | $957.88B | $983.75B | $938.43B | $855.46B | -2.6% |
| Shares issued | 16.50M | 16.90M | 16.90M | 16.90M | -2.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$25.14B | $48.83B | $81.24B | $41.34B | -151.5% |
| Depreciation & amortisation | $38.97B | $42.21B | $41.90B | $41.55B | -7.7% |
| Change in working capital | $31.72B | -$2.73B | $47.84B | -$108.87B | +1,262.7% |
| Operating cash flow | $140.11B | $76.00B | $137.07B | -$59.50B | +84.3% |
| Capital expenditure | -$28.51B | -$18.51B | -$12.42B | -$12.68B | -54.0% |
| Investing cash flow | -$14.96B | -$252.46B | -$1.90B | $99.53B | +94.1% |
| Dividends paid | -$5.77B | -$4.11B | -$4.11B | -$4.11B | -40.4% |
| Financing cash flow | -$140.97B | $91.28B | -$36.74B | -$49.00B | -254.4% |
| Free cash flow | $111.60B | $57.49B | $124.65B | -$72.18B | +94.1% |
| End cash position | $84.67B | $100.58B | $185.38B | $86.79B | -15.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $334.34B | $350.45B | $347.68B | $336.32B | $340.75B | -4.6% |
| Operating revenue | $334.34B | $350.45B | $347.68B | $336.32B | $340.75B | -4.6% |
| Cost of revenue | $270.37B | $280.37B | $277.75B | $269.60B | $274.48B | -3.6% |
| Gross profit | $63.97B | $70.08B | $69.93B | $66.72B | $66.26B | -8.7% |
| Research & development | $154.28M | $63.55M | $226.80M | $155.67M | $165.94M | +142.8% |
| Selling, general & admin | $30.13B | $28.47B | $26.62B | $25.29B | $25.26B | +5.8% |
| Total operating expense | $56.99B | $149.48B | $53.37B | $51.72B | $50.60B | -61.9% |
| Operating income | $6.98B | -$79.40B | $16.56B | $15.00B | $15.66B | +108.8% |
| Net interest income | $1.37B | $6.71B | -$646.22M | $2.59B | $627.20M | -79.5% |
| Pre-tax income | $10.06B | -$73.58B | $26.20B | $27.65B | $15.00B | +113.7% |
| Tax provision | $2.70B | $9.18B | $3.32B | $4.23B | $3.67B | -70.6% |
| Net income | $7.31B | -$82.78B | $22.84B | $23.37B | $11.30B | +108.8% |
| Net income to common | $7.31B | -$82.78B | $22.84B | $23.37B | $11.30B | +108.8% |
| Basic EPS | 43.90 | — | 1,373.10 | 1,405.20 | 67.90 | — |
| Diluted EPS | 43.90 | — | 1,373.10 | 1,405.20 | 67.90 | — |
| EBIT | $12.65B | -$70.27B | $29.91B | $30.88B | $18.61B | +118.0% |
| EBITDA | $22.35B | -$60.48B | $39.59B | $40.65B | $28.33B | +137.0% |
| Basic shares | 166.34M | — | 16.63M | 16.63M | 16.63M | — |
| Diluted shares | 166.34M | — | 16.63M | 16.63M | 16.63M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $63.84B | $84.67B | $76.50B | $70.41B | $75.04B | — | -24.6% |
| Cash & short-term investments | $362.90B | $377.31B | $429.45B | $411.42B | $361.69B | — | -3.8% |
| Accounts receivable | $159.46B | $154.31B | — | — | $177.21B | $174.99B | +3.3% |
| Inventory | $178.79B | $181.45B | $204.54B | $199.68B | $191.81B | — | -1.5% |
| Total current assets | $714.00B | $727.29B | $810.33B | $788.52B | $740.01B | — | -1.8% |
| Property, plant & equipment | $346.36B | $349.33B | $349.77B | $351.60B | $342.47B | — | -0.9% |
| Goodwill & intangibles | $49.78B | $50.06B | $50.60B | $50.92B | $51.84B | — | -0.6% |
| Total assets | $1.52T | $1.53T | $1.61T | $1.57T | $1.50T | — | -0.7% |
| Total current liabilities | $457.76B | $474.81B | $470.58B | $443.89B | $418.21B | — | -3.6% |
| Current debt | $233.47B | $238.92B | $318.72B | $306.76B | $273.30B | — | -2.3% |
| Long-term debt | $16.20B | $12.70B | $12.70B | $20.26B | $6.50B | — | +27.6% |
| Total debt | $289.04B | $292.00B | $373.68B | $370.71B | $323.89B | — | -1.0% |
| Total liabilities | $512.03B | $525.62B | $520.25B | $501.73B | $462.48B | — | -2.6% |
| Retained earnings | $960.21B | $959.50B | $1.04T | $1.02T | $995.75B | — | +0.1% |
| Shareholder equity | $1.01T | $1.01T | $1.09T | $1.07T | $1.04T | — | +0.3% |
| Working capital | $256.23B | $252.48B | $339.75B | $344.63B | $321.80B | — | +1.5% |
| Net tangible assets | $961.38B | $957.88B | $1.04T | $1.02T | $988.93B | — | +0.4% |
| Shares issued | 16.90M | 16.50M | 16.90M | 16.90M | 16.90M | — | +2.4% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $7.35B | -$82.76B | $22.88B | $23.42B | $11.33B | — | +108.9% |
| Depreciation & amortisation | $9.70B | $9.79B | $9.68B | $9.78B | $9.72B | — | -0.9% |
| Change in working capital | -$15.26B | $18.22B | $14.21B | $3.07B | -$3.78B | — | -183.8% |
| Operating cash flow | -$160.26M | $47.26B | $38.77B | $31.12B | $22.96B | — | -100.3% |
| Capital expenditure | -$2.01B | -$7.34B | -$3.60B | -$14.62B | -$2.95B | — | +72.7% |
| Investing cash flow | -$8.72B | $65.62B | -$32.22B | -$61.28B | $12.92B | — | -113.3% |
| Dividends paid | — | $0 | $0 | — | — | $0 | — |
| Financing cash flow | -$12.11B | -$104.75B | -$553.27M | $25.78B | -$61.45B | — | +88.4% |
| Free cash flow | -$2.17B | $39.92B | $35.17B | $16.51B | $20.00B | — | -105.4% |
| End cash position | $63.84B | $84.67B | $76.50B | $70.41B | $75.04B | — | -24.6% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Mar 2015 | 696.89 | 614.20 | -11.9% |
| Dec 2014 | 664.65 | — | — |
| Sep 2014 | 497.65 | 681.20 | +36.9% |
| Jun 2014 | 703.43 | 767.03 | +9.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders43.05%
Held by institutions1.39%
Institutions holding12
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
11,656.00
+0.03% from price
SMA 20
11,501.00
+1.38% from price
SMA 50
11,297.80
+3.21% from price
SMA 100
12,669.10
-7.97% from price
SMA 200
13,650.70
-14.58% from price
EMA 12
11,577.53
+0.71% from price
EMA 26
11,498.94
+1.40% from price
EMA 50
11,674.78
-0.13% from price
RSI (14)
55.0
Neutral
MACD (12,26,9)
78.59
Hist 1.13
ATR (14)
315.00
2.70% of price
Realised vol 30D
22.8%
Annualised
Bollinger upper
12,025.02
20, 2σ
Bollinger lower
10,976.98
20, 2σ
50 / 200 cross
Death
11,297.80 vs 13,650.70
Trend bias
Below 200
-14.58%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.05
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
22.8%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-33.8%
Peak to trough
Max drawdown 5Y
-45.0%
Peak to trough
ATR 14
315.00
2.70% of price
Beta (reported)
0.39
5Y monthly, from filing
Dividends & splits
Forward rate$400.00 / yr
Forward yield3.43%
5-year avg yield2.07%
Payout ratio9.59%
Ex-dividend dateDec 29, 2025
Next pay date—
Last split10:1
Split dateMay 18, 2026
Headlines
Neora Wins Gold at the 2026 Arte of Beauty Awards for Best Anti-Aging Product with Neo-FILLER Lift + Fill Corrective Elixir
PR Newswire · 4m ago
CrankWheel Urges Insurance Agencies to Eliminate Sales Technology Friction Ahead of Open Enrollment
PR Newswire · 4m ago
Leadership Catalyst Pia Jansson Launches Two Books Exploring What Shapes Us and How Leaders Reconnect with Their Edge
PR Newswire · 6m ago
Sealed Air launches compact paper cushioning machine
Packaging Gateway · 6m ago
German economy grows faster than estimated as exports rebound
Euronews · 7m ago
Fifth Annual Screening Saves Lives: Karmanos Cancer Institute Encourages Community to Get Caught Up on Cancer Screenings This October
PR Newswire · 8m ago
Explainer-Why the bond market may be resetting expectations about the US
Reuters · 9m ago
Amplio Spine™ Appoints Nomen Azeem, MD, as Chief Clinical Officer and Founding Chair of the Clinical Advisory Board
PR Newswire · 9m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.